Quanterix (QTRX) Asset Writedowns and Impairment (2021 - 2026)
Quanterix (QTRX) reported Asset Writedowns and Impairment of $305000.0 for Q1 2026, up 475.47% on a YoY basis from $53000.0 in Q1 2025, and down 95.92% quarter-over-quarter from $7.5 million in Q4 2025.
Quanterix (QTRX) Asset Writedowns and Impairment (2021 - 2026) Analysis & Trends
Quanterix has reported Asset Writedowns and Impairment for 6 years, with the latest figure at $305000.0 in Q1 2026.
- For the quarter ending Q1 2026, Asset Writedowns and Impairment rose 475.47% year-over-year to $305000.0; the trailing twelve-month figure through Mar 2026 stood at $8.4 million (up 1371.48% YoY), and the FY2025 full-year result was $7.8 million, up 1218.37% from the prior year.
- Asset Writedowns and Impairment for Q1 2026 stood at $305000.0, down from $7.5 million in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $8.7 million in Q3 2022, with the low at -$403000.0 in Q4 2022.
- Historically, Asset Writedowns and Impairment has averaged $1.1 million across 5 years, with a median of $146000.0 in 2023.
- Annual changes were most pronounced in 2022 — Asset Writedowns and Impairment plunged 955.0% — and 2025, when it surged 4887.18%.
- Quanterix's Asset Writedowns and Impairment stood at -$403000.0 in 2022, then surged by 360.55% to $1.0 million in 2023, then tumbled by 114.86% to -$156000.0 in 2024, then surged by 4887.18% to $7.5 million in 2025, then tumbled by 95.92% to $305000.0 in 2026.
- The last three Asset Writedowns and Impairment figures came in at $305000.0 (Q1 2026), $7.5 million (Q4 2025), and $900000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Quanterix | 159.26 Mn | 59.99 Mn | 15.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 305,000.00 |
| Mar 31, 2026 | 305,000.00 |
| Dec 31, 2025 | 7.47 Mn |
| Dec 31, 2025 | 7.47 Mn |
| Sep 30, 2025 | 900,000.00 |
| Sep 30, 2025 | 900,000.00 |
| Jun 30, 2025 | -315,000.00 |
| Jun 30, 2025 | -315,000.00 |
| Mar 31, 2025 | 53,000.00 |
| Mar 31, 2025 | 53,000.00 |
| Dec 31, 2024 | -156,000.00 |
| Dec 31, 2024 | -156,000.00 |
| Sep 30, 2024 | 68,000.00 |
| Sep 30, 2024 | 68,000.00 |
| Jun 30, 2024 | 603,000.00 |
| Jun 30, 2024 | 603,000.00 |
| Mar 31, 2024 | 73,000.00 |
| Mar 31, 2024 | 73,000.00 |
| Dec 31, 2023 | 1.05 Mn |
| Dec 31, 2023 | 1.05 Mn |